Wuhan General Gr Stock Fundamentals
| WUHNDelisted Stock | USD 0.0004 0.00 0.00% |
Wuhan General Gr fundamentals help investors to digest information that contributes to Wuhan General's financial success or failures. It also enables traders to predict the movement of Wuhan Pink Sheet. The fundamental analysis module provides a way to measure Wuhan General's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Wuhan General pink sheet.
Wuhan |
Wuhan General Gr Company Shares Outstanding Analysis
Wuhan General's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Wuhan General Shares Outstanding | 33.93 M |
Most of Wuhan General's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Wuhan General Gr is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, Wuhan General Gr has 33.93 M of shares currently outstending. This is 81.21% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The shares outstanding for all United States stocks is 94.07% higher than that of the company.
Wuhan General Gr Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Wuhan General's current stock value. Our valuation model uses many indicators to compare Wuhan General value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Wuhan General competition to find correlations between indicators driving Wuhan General's intrinsic value. More Info.Wuhan General Gr is rated third in return on equity category among related companies. It is rated first in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Wuhan General by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Wuhan General's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Wuhan General's earnings, one of the primary drivers of an investment's value.Wuhan Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Wuhan General's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Wuhan General could also be used in its relative valuation, which is a method of valuing Wuhan General by comparing valuation metrics of similar companies.Wuhan General is currently under evaluation in shares outstanding category among related companies.
Wuhan Fundamentals
| Return On Equity | -0.0878 | ||||
| Return On Asset | -0.005 | ||||
| Profit Margin | (0.13) % | ||||
| Operating Margin | (0.03) % | ||||
| Current Valuation | 3.05 M | ||||
| Shares Outstanding | 33.93 M | ||||
| Number Of Shares Shorted | 12.62 K | ||||
| Price To Earning | (0.06) X | ||||
| Price To Book | 0.04 X | ||||
| Price To Sales | 0.05 X | ||||
| Revenue | 80.38 M | ||||
| Gross Profit | 14.54 M | ||||
| EBITDA | 379.92 K | ||||
| Net Income | (10.59 M) | ||||
| Cash And Equivalents | 18.79 M | ||||
| Cash Per Share | 0.55 X | ||||
| Total Debt | 118.8 M | ||||
| Debt To Equity | 1.11 % | ||||
| Current Ratio | 1.10 X | ||||
| Book Value Per Share | 2.34 X | ||||
| Cash Flow From Operations | (21.86 M) | ||||
| Short Ratio | 0.15 X | ||||
| Earnings Per Share | (0.35) X | ||||
| Number Of Employees | 700 | ||||
| Beta | 1.94 | ||||
| Market Capitalization | 3.05 M | ||||
| Total Asset | 286.58 M | ||||
| Retained Earnings | 15 M | ||||
| Working Capital | 18 M | ||||
| Current Asset | 197 M | ||||
| Current Liabilities | 179 M | ||||
| Net Asset | 286.58 M |
About Wuhan General Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Wuhan General Gr's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Wuhan General using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Wuhan General Gr based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Wuhan General Group , Inc., through its subsidiaries, researches, develops, and commercializes a range of cannabidiol -based products under the Dr. Wuhan General Group , Inc. is headquartered in Pointe-Claire, Canada. Wuhan General operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 700 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Wuhan General in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Wuhan General's short interest history, or implied volatility extrapolated from Wuhan General options trading.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Wuhan General Gr information on this page should be used as a complementary analysis to other Wuhan General's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Consideration for investing in Wuhan Pink Sheet
If you are still planning to invest in Wuhan General Gr check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Wuhan General's history and understand the potential risks before investing.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |